FierceBiotech

Mylan Receives Tentative FDA Approval for First-to-File Generic Version of Blood Pressure Drug Benicar HCT

PITTSBURGH, Oct. 22 /PRNewswire-FirstCall/ -- Mylan Inc. (NYSE: MYL - News) today announced that its subsidiary, Mylan Pharmaceuticals Inc., received tentative ...
Nasdaq

Mylan Brings Critical Access to the Multiple Sclerosis Community by Launching a More Affordable Treatment Option Through a First Generic to Tecfidera®

HERTFORDSHIRE, England and PITTSBURGH, Aug. 19, 2020 /PRNewswire/ -- Mylan N.V. (NASDAQ: MYL) today announced the launch of the first FDA-approved therapeutically equivalent, substitutable generic of ...
Business Insider

Mylan and Pfizer Receive Clearance from the U.S. Federal Trade Commission for Proposed Combination of Mylan and Upjohn

HERTFORDSHIRE, England and PITTSBURGH and NEW YORK, Oct. 30, 2020 /PRNewswire/ -- Mylan N.V. (NASDAQ: MYL) and Pfizer Inc. (NYSE: PFE) today announced that the U.S. Federal Trade Commission (the "FTC" ...
FierceBiotech

Mylan Reports That the FDA Determined That All Accusations Were Unfounded

PITTSBURGH, July 28 /PRNewswire-FirstCall/ -- Mylan Inc. (NASDAQ: MYL) today reported that in addition to the press release it issued on Sunday, the company ...
Business Insider

Mylan and Biocon Launch Fulphila®, Biosimilar Pegfilgrastim, in Canada

HERTFORDSHIRE, England, PITTSBURGH and BENGALURU, India, April 28, 2020 /CNW/ -- Mylan N.V. and Biocon Ltd. (BSE code: 532523, NSE: BIOCON) today announced the launch of Fulphila ®, a biosimilar to ...
Monthly Prescribing Reference

Mylan Launches Generic Version of Tecfidera for MS

This is the first FDA-approved therapeutically equivalent, substitutable generic of Tecfidera. Mylan announced the launch of Dimethyl Fumarate Delayed-Release Capsules, the first Food and Drug ...